Matthew Ros - 01 Jul 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jul 2022, 13:51:42 UTC
Prior SEC filing
09 Jun 2022
Next SEC filing
04 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Evan D. Kearns, Attorney-in-Fact

Key filing fact

Matthew Ros filed Form 4 for Cogent Biosciences, Inc. (COGT) on 05 Jul 2022.

Key facts

  • This page summarizes Matthew Ros's Form 4 filing for Cogent Biosciences, Inc. (COGT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 Jul 2022, 13:51.

Change

  • Previous filing in this sequence was filed on 09 Jun 2022.
  • Current net transaction value: +$12,880.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

COGT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$12,880
Shares
+2,194
Change %
Price
$5.87
Shares after
2,194
Date
01 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,194
Exercise price
$9.39
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .